Hemodynamic surrogate end-points in phase I studies?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 4, 1997, Pages 175-179

  De Mey, C ^a,b  

^a IPHAR Inst for Clin Pharmacology   (Germany)

^b IPHAR Inst Clin Pharmacol GmbH   (Germany)

Author keywords

Healthy volunteers; Human pharmacology; Phase I; Surrogate end points

Indexed keywords

ARTICLE; CLINICAL PHARMACOLOGY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ELECTROCARDIOGRAM; HUMAN; PHASE 1 CLINICAL TRIAL;

CLINICAL TRIALS, PHASE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HUMANS; PHARMACOKINETICS; PHARMACOLOGY, CLINICAL; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; THERAPEUTIC EQUIVALENCY; VOLUNTARY WORKERS;

EID: 0031004150     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agostoni PG, de Cesare N, Doria E, Polese A, Tamborini G, Guazzi MD 1986 Afterload reduction: a comparison between captopril and nifedipine in dilated cardiomyopathy. Br Heart J 55: 391-399
2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH 1990 Blood pressure, stroke and coronary heart disease. Lancet 335: 837-838
3. De Mey C, Hansen-Schmidt S, Enterling D 1988 Postprandial hemodynamic changes: a source of bias in cardiovascular research affected by its own methodological bias. Cardiovasc Res 22: 703-707
4. De Mey C, Enterling D 1988 Variant responses impair the usefulness of passive upright tilt in drug research. Meth Find Exp Clin Pharmacol 10: 57-64
5. De Mey C, Beiz GG, Nixdorf U, Butzer R, Schroeter V, Meyer J, Erbel R 1992 Relative sensitivity of four methods in assessing systolic cardiovascular effects of isoprenaline in healthy volunteers. Clin Pharmacol Ther 52: 609-619
6. 1 adrenoceptor occupancies. Br J Clin Pharmacol 38: 480-483
7. 1-adrenoceptor blocking properties of various doses of carvedilol in healthy man. Clin Pharmacol Ther 55: 329-337
8. De Mey C 1995 Method specificity of the auscultatory estimates of the inodilatory reduction of diastolic blood pressure based on Korotkoff-IV and -V criteria. Br J Clin Pharmacol 39: 485-490
9. De Mey C, Schroeter V, Butzer R, John P, Wetterich U, Terhaag B, Mutschler E, Spahn Langguth H, Palm D, Beiz GG 1995 Dose-effect and kinetic-dynamic relationships of the β-adrenoceptor blocking properties of various doses of talinolol in healthy man. J Cardiovasc Pharmacol 26: 879-888
10. De Mey C, Schroeter V, Butzer R, Roll S, Beiz GG 1995 Method specificity of noninvasive blood pressure measurement: oscillometry and finger pulse pressure vs. acoustic methods. Br J Clin Pharmacol 40: 291-297
11. De Mey C, Erb KA 1997 Usefulness, usability and quality criteria of noninvasive methods in cardiovascular clinical pharmacology. J Clin Pharmacol 37 (Suppl 1): 115-205
12. De Mey C, Erb K, Schroeter V, Beiz GG 1996 Differentiation of inodilatory responses by noninvasive measures of cardiovascular performance in healthy man. Int J Clin Pharmacol Ther 12: 525-532
13. Erb K, Stammer H, de Mey C 1997 Valuation of the noninvasive estimates of cardiac output by Doppler aortoechography according to test-theoretic principles. Int J Clin Pharmacol Ther 35: 170-174
14. Kleinbloesem CH, van Brummelen P, Danhof M, Faber H, Urquhart J, Breimer DD 1987 Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther 41: 26-30
15. Leier CV, Huss PM, Magorien RD, Unverferth DV 1983 Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for heart failure. Circulation 67:817-822
16. Packer M, Medina N, Yushak M 1984 Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation 70: 1038-1047
17. Prentice RL 1989 Surrogate end-points in clinical trials: definition and operational criteria. Stat Med 8: 431-440
18. Stinson JC, Pears JS, Williams AJ, Campbell WF 1995 Use of ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers. Br J Clin Pharmacol 39: 651-655